PHILADELPHIA - The Pennsylvania federal judge overseeing the budeprion XL multidistrict litigation on Sept. 20 denied a motion by the Texas attorney general to intervene in an approved class settlement of litigation involving the generic version of Wellbutrin XL antidepressant (In Re: Budeprion XL Marketing & Sales Litigation, MDL Docket No. 2107, No. 09-md-2107, E.D. Pa.; 2012 U.S. Dist. LEXIS 135313).